Secondary immune responses to measles virus are characterized by a rise in 7S measles antibodies with little or no 19S antibody production. Sera collected a month after challenge with live measles vaccine of 9-month-old infants who had received inactivated measles vaccine before they were 7 months of age revealed 19S antibodies in 50% of postchallenge sera tested. Suppression of 19S antibody formation in the other 50% was well correlated with resistance to the clinical effects of measles and provided a more sensitive measure of immunization during the maternal antibody period than seroconversion or incidence of clinical reactions to challenge.
No takes yet. Share an insight, caveat, or question.
Ann Schluederberg (1965) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: